In an incredible move on Friday, the FDA approved Endari for the treatment of patients age five and older with sickle cell disease to reduce severe complications that are common with the blood disorder.
Athenex led biotech stocks higher on Wednesday after its Chinese subsidiary submitted an Investigational New Drug application to the China Food and Drug Administration.
Array BioPharma has announced the submission to the FDA of two New Drug Applications to support the use of the combination of binimetinib and encorafenib for the treatment of patients with melanoma.
A drop in the exposure to lead among children in their preschool years reduces antisocial behavior and may be a factor behind the decline in crime over the past few decades.
A new report details the extent of Americans’ drug consumption, which are the narcotics of choice, which states' residents spend the most to get the drugs and what some people are willing to do…
The June 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks shrank.
Agio Pharmaceuticals saw its shares sink on Monday after the firm announced results from its midstage trial for the treatment of relapsed or refractory acute myeloid leukemia.
Cara Therapeutics saw its shares rise on Friday after the company said that the FDA granted a Breakthrough Therapy designation on its uremic pruritus treatment.